• Ultrasound and Gas Bubbles May One Day Deliver Alzheimer’s Treatments Directly to Brain
  • ProMIS Biotech Hopes to Prove Amyloid Theory in Alzheimer’s with New Targeted Therapies
  • Menopause May Be Reason More Women Develop Alzheimer’s Than Men
  • Long-term Opioid Use Common in Alzheimer’s Patients, But Not Excessive, Finnish Study Says
  • Dementia Cases Declined by 24% in US Between 2000-12, Study Reports
  • Failure of Lilly’s Solanezumab Not Seen as Conclusive Proof That Amyloid Theory Is Flawed
  • Alzheimer’s Association Grant Furthers Research into Obesity, Brain Aging and Dementia
  • Anavex’s Experimental Alzheimer’s Treatment Prevents Mental-acuity Decline in Clinical Trial
  • In Surprise Finding, Tau Enzyme Seen in Early Alzheimer’s Stages to Protect Neurons
  • 1st Alzheimer’s Patient Dosed in Clinical Trial of Amyloid Beta ‘Displacer’
  • Brain Training May Ward Off Dementia, but Only in Earliest Stages of Decline
  • Probiotics Trial in Alzheimer’s Patients Shows Promise in Improving Brain Function